Paulo V. Campregher
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
From Sequencing to Treatment: Operational Challenges in Translating Precision Oncology Into Clinical Practice.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 04, 2026
Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape.
Journal: European journal of pharmacology
Published: February 21, 2026
Diagnostic performance, molecular analysis, and complications in CT-guided percutaneous biopsies of lung nodules with 20-gauge needles.
Journal: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Published: February 04, 2026
Very High vs. High Tumor Mutational Burden Across Tumors: Real-World Associations with MSI, Pathway Features, and Immunotherapy Outcomes.
Journal: Biomedicines
Published: January 26, 2026
Precision diagnosis and therapy for pediatric central nervous system tumors: consensus from the Brazilian Society of Pediatric Oncology (SOBOPE).
Journal: Lancet regional health. Americas
Published: October 28, 2025
Periostin-positive stellate cells associated with perineural invasion in pancreatic adenocarcinoma.
Journal: Molecular and cellular endocrinology
Published: August 07, 2025
Interpreting the functional impact of genetic variants: The need for context qualifiers.
Journal: American journal of human genetics
Published: July 16, 2025
Real-world genomic profiling of solid tumors: validation and clinical insights from a Brazilian cohort.
Journal: Einstein (Sao Paulo, Brazil)
Published: July 11, 2025
Mutational signatures in hematological malignancies.
Journal: Einstein (Sao Paulo, Brazil)
Published: June 24, 2025
Precision medicine with car cells in acute myeloid leukemia: where are we?
Journal: Frontiers in immunology
Published: June 24, 2025
Metabolic reprogramming represents a targetable mechanism to overcome acquired resistance to venetoclax in acute myeloid leukemia.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 08, 2025
Last Updated: 09/26/2026